Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. April 2026 09:15 ET | Quelle: Navient Corporation

Navient to announce first quarter 2026 results, host earnings webcast April 29

HERNDON, Va., April 03, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) will host an audio webcast to review its first quarter 2026 results on Wednesday, April 29, 2026, at 8:00 a.m. Eastern Time. ...
03. April 2026 09:00 ET | Quelle: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Announces Changes to Board of Directors

-- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage...
03. April 2026 08:30 ET | Quelle: Bicara Therapeutics Inc.

Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...
03. April 2026 08:00 ET | Quelle: Lotus Technology Inc.

Lotus Showcases Emira Racing Line Edition at the New York International Auto Show

Highlight Lotus’ core luxury sports car lineup with the Emira at one of North America’s premier automotive eventsThe Racing Line Edition blends Lotus’ legendary engineering heritage with contemporary,...
03. April 2026 08:00 ET | Quelle: MBX Biosciences, Inc.

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CARMEL, Ind., April 03, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...
03. April 2026 08:00 ET | Quelle: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, April 03, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus...
03. April 2026 07:30 ET | Quelle: Figure Technology Solutions, Inc.

Figure Technology Solutions Reports Preliminary March & Q1 2026 Operating Data

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale, and trading...
03. April 2026 07:30 ET | Quelle: MiNK Therapeutics

MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026

Study will highlight novel iNKT cell-based combinations in checkpoint-refractory diseaseData expected to inform immune modulation, treatment sequencing strategy, and clinical durability of response ...
03. April 2026 07:30 ET | Quelle: Kura Oncology, Inc.

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the...
03. April 2026 07:00 ET | Quelle: Village Farms International, Inc.

Village Farms Announces Succession Plan for Chief Financial Officer

Stephen Ruffini will transition from CFO after 17 years of service to assume responsibility for M&A activities Mr. Ruffini will remain CFO until a permanent replacement is identified; Company...

Vorherige Seite

Nächste Seite